1. 1. Ellis GB. ‘Dear Colleague’ letter: human subjects protections. OPRR Rep. Aug 12, 1993; 93-3.
2. 2. Hearings before the Subcommittee on Regulation, Business Opportunities and Technology of the Committee on Small Business of the United States House of Representatives, 103rd Congress, 2nd Session (May 23, 1994) (Testimony of Gary Ellis, PhD, Director, Office for Protection from Research Risks, National Institutes of Health).
3. 3. Hearings before the Subcommittee on Regulation, Business Opportunities and Technology of the Committee on Small Business of the United States House of Representatives, 103rd Congress, 2nd Session (May 23, 1994) (Testimony of Mary Pendergast, Deputy Commissioner and Senior Advisor to the Commissioner, Food and Drug Administration).
4. Consensus development: a historical note;Perry;Int J Technol Assess Health Care.,1988
5. The technology assessment and practice guidelines forum: a modified group judgement method;Perry;Int J Technol Assess Health Care.,1992